Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 12:00 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 267 matching trials from the live ClinicalTrials.gov search.

Filters: Sponsor: John Clear all

Conditions: Glioblastoma
Interventions: CMV-ALT + CMV-DCs, CMV-ALT + Saline; Biological
Lead sponsor: John Sampson; Other
Eligibility: 18 Years and older
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2015
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Prostate Adenocarcinoma
Interventions: Polymer based fiducial placement; Other
Lead sponsor: John Chang, MD; Other
Eligibility: Male only
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2011
U.S. locations: 1
States / cities: Warrenville, Illinois

Conditions: Hernia Repair With Compartment Syndrome
Interventions: Flex HD, Strattice; Device
Lead sponsor: John Roth; Other
Eligibility: 18 Years to 85 Years
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Obesity
Interventions: Standard weight loss intervention, Standard weight loss intervention plus technology, Technology only; Behavioral
Lead sponsor: John M. Jakicic, PhD; Other
Eligibility: 18 Years to 55 Years
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Osteoarthritis, Knee
Interventions: Recombinant human growth hormone; Drug
Lead sponsor: John Sledge; Other
Eligibility: 18 Years to 72 Years
Enrollment: 23 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Santa Monica, California

Conditions: Preeclampsia
Interventions: Aspirin, Placebo Oral Tablet, Progesterone; Drug
Lead sponsor: John Uckele; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Royal Oak, Michigan

Conditions: Graft-versus-host-disease, GVHD
Interventions: Alpha 1-Antitrypsin; Drug
Lead sponsor: John Levine; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 5
States / cities: Duarte, California • Boston, Massachusetts • New York, New York + 2 more

Conditions: Crime, Juvenile Delinquency
Interventions: Big Brothers Big Sisters Community-Based Mentoring Program; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 10 Years and older
Enrollment: 1,361 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2025
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Opioid Use
Interventions: Modification of opioid prescription method; Other
Lead sponsor: John Yanik; Other
Eligibility: 18 Years and older
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Arthritis
Interventions: Theraworx, Placebo; Drug
Lead sponsor: John Fowler; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 3
States / cities: Pittsburgh, Pennsylvania

Conditions: Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Clinically Isolated Syndrome
Interventions: Not listed
Lead sponsor: John F. Foley, MD; Other
Eligibility: 18 Years to 68 Years
Enrollment: 49 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Mucinous Adenocarcinoma of the Colon, Mucinous Adenocarcinoma of the Rectum, Signet Ring Adenocarcinoma of the Colon, Signet Ring Adenocarcinoma of the Rectum, Stage IV Colon Cancer, Stage IV Rectal Cancer
Interventions: aflibercept, oxaliplatin, leucovorin, fluorouracil, Correlative Studies, DCE MRI, f18FDG-PET, PET (positron emission tomography); Biological · Drug · Other + 2 more
Lead sponsor: John Hays; Other
Eligibility: 18 Years and older
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2022
U.S. locations: 6
States / cities: Ann Arbor, Michigan • Buffalo, New York • The Bronx, New York + 3 more

Conditions: Maternal-Fetal Relations
Interventions: 3D printed model, Placebo; Other
Lead sponsor: Creighton University; Other
Eligibility: 19 Years to 45 Years · Female only
Enrollment: 96 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Accelerated/Blast-phase Myeloproliferative Neoplasm, Chronic-phase Myelofibrosis, IDH2 Mutation
Interventions: Ruxolitinib, Enasidenib; Drug
Lead sponsor: John Mascarenhas; Other
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 10
States / cities: Scottsdale, Arizona • Los Angeles, California • Tampa, Florida + 6 more

Conditions: Hallux Rigidus
Interventions: Hallux Rigidus Treatment; Procedure
Lead sponsor: John Femino; Other
Eligibility: 18 Years to 75 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Heart Defects, Congenital
Interventions: nesiritide, milrinone, placebo; Drug
Lead sponsor: John M Costello; Other
Eligibility: Not listed
Enrollment: 106 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2013
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: First Episode Psychosis, Youth
Interventions: Narrative Enhancement and Cognitive Therapy- Young Adult, Combined with Coordinated Specialty Care, Coordinated Specialty Care; Behavioral · Other
Lead sponsor: John Jay College of Criminal Justice, City University of New York; Other
Eligibility: 15 Years to 24 Years
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Soft Tissue Sarcoma, Sarcoma,Soft Tissue
Interventions: Talimogene Laherparepvec, Neoadjuvant Radiation, Surgery; Drug · Radiation · Procedure
Lead sponsor: John Rieth; Other
Eligibility: 18 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2031
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Recurrent Central Nervous System Neoplasm
Interventions: BTSC mRNA-loaded DCs; Biological
Lead sponsor: John Sampson; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2016
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Cannabis Use, Drug Use, Development, Infant
Interventions: No Intervention will be used; Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 40 Years
Enrollment: 92 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Neonatal Abstinence Syndrome, Aromatherapy
Interventions: lavender and chamomile essential oils; Drug
Lead sponsor: John M. Daniel; Other
Eligibility: Up to 2 Weeks
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Stage III Pancreatic Cancer
Interventions: porfimer sodium, endoscopic ultrasonography, photodynamic therapy, gemcitabine hydrochloride; Drug · Procedure
Lead sponsor: John DeWitt; Other
Eligibility: 18 Years to 60 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2018
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Chronic Kidney Disease, Glomerulopathy
Interventions: Not listed
Lead sponsor: University of Michigan; Other
Eligibility: Not listed
Enrollment: 1,800 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2030
U.S. locations: 5
States / cities: Ann Arbor, Michigan • Detroit, Michigan • Charlotte, North Carolina + 1 more

Conditions: Schizophrenia, Depression
Interventions: Procedural; Other
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 55 Years
Enrollment: 25 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2014
U.S. locations: 2
States / cities: New Haven, Connecticut • West Haven, Connecticut

Search by objective public record fields.

Evaluation of Recovery From Drug-Induced Lymphopenia Using Cytomegalovirus-specific T-cell Adoptive Transfer

An Evaluation of Polymer Based Fiducials for Use in Imaging Patients Receiving Treatment for Prostate Cancer

Feasibility Study of The Use of FLEX HD® Surgical Implant or STRATTICE® Reconstructive Tissue Matrix in The Closure of Abdominal Wall Defects With Component Separation in Clean or Contaminated Cases

The Comparison of a Technology-Based System and an In-Person Behavioral Weight Loss Intervention

Human Growth Hormone Injections in the Knee Joint to Treat Osteoarthritis

Oral Progesterone and Low Dose Aspirin in the Prevention of Preeclampsia

A Proof of Concept Pilot Trial of Alpha-1-Antitrypsin for Pre-Emption Of Steroid-Refractory Acute GVHD

Randomized Controlled Trial of Big Brothers Big Sisters Mentoring for Prevention of Crime and Delinquency

Does Altering Narcotic Prescription Methods Affect Opioid Distribution Following Select Upper Extremity Surgeries?

Impact of TheraWorx Foam on Symptom Relief in Thumb Arthritis

A Pilot Study to Assess microRNA Biomarkers in Early and Later Stage Multiple Sclerosis

Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer

Third Trimester 3D Printed Models Versus 3D Ultrasound Effects on Maternal-Fetal Attachment

Combined Ruxolitinib and Enasidenib in Patients With Accelerated/Blast-phase Myeloproliferative Neoplasm or Chronic-phase Myelofibrosis With an IDH2 Mutation

Synthetic Cartilage Implant Versus Interposition Arthroplasty in Hallux Rigidus Treatment: A Randomized Clinical Trial

Effects of Perioperative Nesiritide or Milrinone Infusion on Recovery From Fontan Surgery

Pilot RCT of Self-stigma Treatment for First Episode Psychosis

Neoadjuvant Intralesional Injection of Talimogene Laherparepvec

Vaccine Therapy in Treating Patients Undergoing Surgery for Recurrent Glioblastoma Multiforme

Intergenerational Effects of Paternal Periconceptional Cannabis and Other Drug Use (EPIC)

The Effect of Aromatherapy on Neonatal Abstinence Syndrome and Salivary Cortisol Levels

Ultrasound-Guided Photodynamic Therapy With Photofrin & Gemcitabine for Patients With Locally Advanced Pancreatic Cancer

Clinical Phenotyping Resource and Biobank Core of the Michigan O'Brien Renal Center

Regulation of Arginine-vasopressin (AVP)